Published in Transfusion on December 24, 1985
Transfusion-related acute lung injury in the critically ill: prospective nested case-control study. Am J Respir Crit Care Med (2007) 3.69
Transfusion-related acute lung injury: incidence and risk factors. Blood (2011) 3.12
Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission. Blood (2004) 2.89
Neutrophils and their Fc gamma receptors are essential in a mouse model of transfusion-related acute lung injury. J Clin Invest (2006) 2.50
Plasma and lipids from stored packed red blood cells cause acute lung injury in an animal model. J Clin Invest (1998) 2.37
Partial characterization of lipids that develop during the routine storage of blood and prime the neutrophil NADPH oxidase. J Lab Clin Med (1994) 2.13
Identification of lipids that accumulate during the routine storage of prestorage leukoreduced red blood cells and cause acute lung injury. Transfusion (2011) 1.87
Characterizing the epidemiology of postoperative transfusion-related acute lung injury. Anesthesiology (2015) 1.76
Microcirculatory effects of the transfusion of leukodepleted or non-leukodepleted red blood cells in patients with sepsis: a pilot study. Crit Care (2014) 1.56
The hazards of blood transfusion in historical perspective. Blood (2008) 1.54
Plasma from stored packed red blood cells and MHC class I antibodies causes acute lung injury in a 2-event in vivo rat model. Blood (2009) 1.49
Characterization of the human neutrophil alloantigen-3a. Nat Med (2009) 1.43
The Epidemiology of Transfusion-related Acute Lung Injury Varies According to the Applied Definition of Lung Injury Onset Time. Ann Am Thorac Soc (2015) 1.39
Reducing noninfectious risks of blood transfusion. Anesthesiology (2011) 1.30
Transfusion-related acute lung injury (TRALI): current concepts and misconceptions. Blood Rev (2009) 1.26
Transfusion-related acute lung injury (TRALI): a clinical review with emphasis on the critically ill. Br J Haematol (2009) 1.23
Adverse effects of plasma transfusion. Transfusion (2012) 1.23
Pulmonary transfusion reactions. Transfus Med Hemother (2008) 1.19
Long-term survival and quality of life after transfusion-associated pulmonary edema in critically ill medical patients. Chest (2009) 1.18
Red blood cell transfusions and the risk of acute respiratory distress syndrome among the critically ill: a cohort study. Crit Care (2007) 1.14
Prospective study on the clinical course and outcomes in transfusion-related acute lung injury*. Crit Care Med (2014) 1.11
Experimental prestorage filtration removes antibodies and decreases lipids in RBC supernatants mitigating TRALI in vivo. Blood (2014) 1.11
Leukocyte antigen and antibody detection assays: tools for assessing and preventing pulmonary transfusion reactions. Transfus Med Rev (2007) 1.07
Clinical review: Early treatment of acute lung injury--paradigm shift toward prevention and treatment prior to respiratory failure. Crit Care (2012) 1.07
The role of neutrophils in the pathogenesis of transfusion-related acute lung injury. Transfus Med Rev (2009) 1.06
MHC class I-specific antibody binding to nonhematopoietic cells drives complement activation to induce transfusion-related acute lung injury in mice. J Exp Med (2011) 1.06
Transfusion-Related Acute Lung Injury: Incidence, Pathogenesis and the Role of Multicomponent Apheresis in Its Prevention. Transfus Med Hemother (2008) 1.05
Identification of specificities of antibodies against human leukocyte antigens in blood donors. Transfusion (2010) 0.98
Transfusion reactions: newer concepts on the pathophysiology, incidence, treatment, and prevention of transfusion-related acute lung injury. Crit Care Clin (2012) 0.97
A preliminary comparison of the prevalence of transfusion reactions in recipients of platelet components from donors with and without human leucocyte antigen antibodies. Vox Sang (2008) 0.97
Fresh and stored red blood cell transfusion equivalently induce subclinical pulmonary gas exchange deficit in normal humans. Anesth Analg (2012) 0.95
Application of the Berlin definition in PROMMTT patients: the impact of resuscitation on the incidence of hypoxemia. J Trauma Acute Care Surg (2013) 0.94
Long-term in vitro reactivity for human leukocyte antigen antibodies and comparison of detection using serum versus plasma. Transfusion (2008) 0.94
TRALI--definition, mechanisms, incidence and clinical relevance. Best Pract Res Clin Anaesthesiol (2007) 0.92
Frequencies of SLC44A2 alleles encoding human neutrophil antigen-3 variants in the African American population. Transfusion (2011) 0.92
The utility of clinical predictors of acute lung injury: towards prevention and earlier recognition. Expert Rev Respir Med (2010) 0.91
Transfusion-related acute lung injury in multiple traumatized patients. Caspian J Intern Med (2012) 0.91
Establishing assay cutoffs for HLA antibody screening of apheresis donors. Transfusion (2011) 0.89
The frequency and specificity of human neutrophil antigen antibodies in a blood donor population. Transfusion (2010) 0.89
Primary total knee arthroplasty allogenic transfusion trends, length of stay, and complications: nationwide inpatient sample 2000-2009. J Arthroplasty (2014) 0.87
The HLA system: genetics, immunology, clinical testing, and clinical implications. Yonsei Med J (2007) 0.86
Comparison of acute non-haemolytic transfusion reactions in female and male patients receiving female or male blood components. Transfus Med (2007) 0.86
The pro-inflammatory effects of platelet contamination in plasma and mitigation strategies for avoidance. Vox Sang (2011) 0.86
Intravenous immunoglobulin prevents murine antibody-mediated acute lung injury at the level of neutrophil reactive oxygen species (ROS) production. PLoS One (2012) 0.85
Transfusion-related acute lung injury (TRALI): current clinical and pathophysiologic considerations. Lung (2006) 0.84
Agreement among HLA antibody detection assays is higher in ever-pregnant donors and improved using a consensus cutoff. Transfusion (2010) 0.84
Transfusion-related acute lung injury in the Canadian paediatric population. Paediatr Child Health (2012) 0.83
Female donors and transfusion-related acute lung injury: A case-referent study from the International TRALI Unisex Research Group. Transfusion (2010) 0.82
The management of hospitalized patients with cirrhosis: the Mount Sinai experience and a guide for hospitalists. Dig Dis Sci (2011) 0.82
Acute respiratory distress syndrome: prevention and early recognition. Ann Intensive Care (2013) 0.81
Transfusion-related acute lung injury after transfusion of maternal blood: a case-control study. Spine (Phila Pa 1976) (2010) 0.81
Full-length nucleotide sequences of 30 common SLC44A2 alleles encoding human neutrophil antigen-3. Transfusion (2015) 0.81
Pulmonary complications after spine surgery. World J Orthop (2012) 0.80
Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation. Cochrane Database Syst Rev (2015) 0.80
Postpartum immunologic-mediated pulmonary edema associated with transfusion of blood containing an anti-B-lymphocyte antibody. West J Med (1989) 0.79
Lot-to-lot variability in HLA antibody screening using a multiplexed bead-based assay. Transfusion (2013) 0.79
High Flow-Mediated Vasodilatation Predicts Pulmonary Edema in Liver Transplant Patients. Zhonghua Minguo Xin Zang Xue Hui Za Zhi (2013) 0.79
A case of transfusion-related acute lung injury induced by anti-human leukocyte antigen antibodies in acute leukemia. Korean J Hematol (2012) 0.78
Acute non-hemolytic transfusion reactions and HLA class I antibody: advantages of solid phase assay compared with conventional complement-dependent assay. Transfus Med (2009) 0.78
Experimental models of transfusion-related acute lung injury. Transfus Med Rev (2011) 0.78
The impact of policies to restrict the use of plasma containing products and apheresis platelets from female donors to mitigate transfusion related acute lung injury (TRALI) in Brazil. Transfus Apher Sci (2012) 0.78
A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation. Cochrane Database Syst Rev (2014) 0.77
Different doses of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation. Cochrane Database Syst Rev (2015) 0.77
Comparison of different platelet transfusion thresholds prior to insertion of central lines in patients with thrombocytopenia. Cochrane Database Syst Rev (2015) 0.77
Alternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation. Cochrane Database Syst Rev (2015) 0.77
Transfusion-related acute lung injury (TRALI)--an important, severe transfusion-related complication. Langenbecks Arch Surg (2006) 0.77
Alternatives, and adjuncts, to prophylactic platelet transfusion for people with haematological malignancies undergoing intensive chemotherapy or stem cell transplantation. Cochrane Database Syst Rev (2016) 0.76
Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation. Cochrane Database Syst Rev (2014) 0.76
Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders. Cochrane Database Syst Rev (2016) 0.76
Different doses of prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation. Cochrane Database Syst Rev (2014) 0.76
Anemia and blood transfusions in critically ill patients. J Blood Transfus (2012) 0.76
Successful extracorporeal membranous oxygenation for a patient with life-threatening transfusion-related acute lung injury. J Anesth (2009) 0.76
Supportive care in patients with acute leukaemia: historical perspectives. Blood Transfus (2014) 0.76
A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation. Cochrane Database Syst Rev (2015) 0.76
Antiplatelet antibody may cause delayed transfusion-related acute lung injury. Int J Gen Med (2011) 0.76
Transfusion-Related Acute Lung Injured (TRALI): Current Concepts. Open Respir Med J (2015) 0.76
A suspected case of transfusion-related acute lung injury. Lung India (2011) 0.75
Evaluation of transfusion pyrexia: a review of differential diagnosis and management. ISRN Hematol (2012) 0.75
Mechanical ventilation and the titer of antibodies as risk factors for the development of transfusion-related lung injury. Crit Care Res Pract (2012) 0.75
TRALI in Perioperative Period-A Case Report. Indian J Anaesth (2009) 0.75
Broken hearts and transfusion-related acute lung injury. Crit Care Med (2012) 0.75
Epidemiology of Transfusion Related Acute Lung Injury in France: Preliminary Results. Transfus Med Hemother (2008) 0.75
Pulmonary complications of transfused blood components. Crit Care Nurs Clin North Am (2012) 0.75
Adult respiratory distress syndrome. Advances in diagnosis and ventilatory management. BMJ (1990) 0.75
Fatal transfusion related acute lung injury following coronary artery by-pass surgery: a case report. Cases J (2008) 0.75
[Trali or acute post-transfusion pulmonary edema: report of a case with review of the literature]. Pan Afr Med J (2015) 0.75
Transfusion related acute lung injury presenting with acute dyspnoea: a case report. J Med Case Rep (2008) 0.75
Genotype frequency of human neutrophil antigen-3 polymorphisms in the Yi, Han, and Tibetan populations of China. Transfusion (2015) 0.75
Therapeutic options for transfusion related acute lung injury; the potential of the G2A receptor. Curr Pharm Des (2012) 0.75
TRALI Syndrome Complicated by Retroperitoneal Bleeding. Int J Angiol (2011) 0.75
A Clinical Trial to Detect Subclinical Transfusion-induced Lung Injury during Surgery. Anesthesiology (2015) 0.75
The Clinical Efficacy of Fibrinogen Concentrate in Massive Obstetric Haemorrhage with Hypofibrinogenaemia. Sci Rep (2017) 0.75
Comparison of different platelet transfusion thresholds prior to insertion of central lines in patients with thrombocytopenia. Cochrane Database Syst Rev (2015) 0.75
The association between red blood cell and platelet transfusion and subsequently developing idiopathic pneumonia syndrome after hematopoietic stem cell transplantation. Transfusion (2013) 0.75
Transfusion Related Acute Lung Injury (TRALI): A Single Institution Experience of 15 Years. Indian J Hematol Blood Transfus (2015) 0.75
A microengineered model of RBC transfusion-induced pulmonary vascular injury. Sci Rep (2017) 0.75
Potential contribution of mitochondrial (mt) DNA Damage Associated Molecular Patterns (DAMPs) in transfusion products to the development of Acute Respiratory Distress Syndrome (ARDS) after multiple transfusions. J Trauma Acute Care Surg (2017) 0.75
Computer-based interview for screening blood donors for risk of HIV transmission. JAMA (1992) 4.01
HLA class II antibodies in transfusion-related acute lung injury. Transfusion (2001) 2.93
The association of biologically active lipids with the development of transfusion-related acute lung injury: a retrospective study. Transfusion (1997) 2.67
A comparison of plasmapheresis versus high-dose IVIG desensitization in renal allograft recipients with high levels of donor specific alloantibody. Am J Transplant (2006) 2.37
Hypotensive reactions: a previously uncharacterized complication of platelet transfusion? Transfusion (1996) 2.37
A controlled trial of educational outreach to improve blood transfusion practice. JAMA (1993) 2.28
Major histocompatibility complex class II alleles and the course and outcome of MS: a population-based study. Neurology (1998) 2.26
Transfusion-related acute lung injury: a neglected, serious complication of hemotherapy. Transfusion (1992) 2.07
Improved serodiagnosis of hepatitis C virus infection with synthetic peptide antigen from capsid protein. Proc Natl Acad Sci U S A (1991) 1.81
Eosinophilic fasciitis: clinical spectrum and therapeutic response in 52 cases. Semin Arthritis Rheum (1988) 1.70
Transfusion-related acute lung injury associated with passive transfer of antileukocyte antibodies. Am Rev Respir Dis (1983) 1.68
Hypotensive reactions: are they a new phenomenon? Are they related solely to transfusion of platelets? Does filtration of components play a role? Transfusion (1996) 1.62
Autoimmune cholangitis within the spectrum of autoimmune liver disease. Hepatology (2000) 1.55
DR human leukocyte antigens and disease severity in chronic hepatitis C. J Hepatol (1996) 1.54
Perioperative blood transfusion and colorectal cancer recurrence: a qualitative statistical overview and meta-analysis. Transfusion (1993) 1.49
Genetic distinctions between types 1 and 2 autoimmune hepatitis. Am J Gastroenterol (1997) 1.49
Transfusion to blood group A and O patients of group B RBCs that have been enzymatically converted to group O. Transfusion (2000) 1.49
A case-controlled multicenter study of vasovagal reactions in blood donors: influence of sex, age, donation status, weight, blood pressure, and pulse. Transfusion (1999) 1.48
Ischemic-type biliary complications after orthotopic liver transplantation. Hepatology (1992) 1.46
Elevated serum levels of the eosinophil granule major basic protein in patients with eosinophilia. J Clin Invest (1981) 1.46
Donor attitudes about exporting and importing blood. Transfusion (1997) 1.43
Host- and disease-specific factors affecting steatosis in chronic hepatitis C. J Hepatol (1998) 1.43
Needlestick injuries in blood collection staff. A retrospective analysis. Transfusion (1989) 1.41
Transplant glomerulopathy: subclinical incidence and association with alloantibody. Am J Transplant (2007) 1.40
Morning admission to the hospital for surgery the same day. A practical problem for the blood bank. Transfusion (1987) 1.39
Infection and America's blood supply: a 1998 status report. Am J Clin Pathol (1998) 1.38
Autologous blood transfusion in the 1990s. Where is it heading? Am J Clin Pathol (1992) 1.38
Evidence against hepatitis viruses as important causes of severe autoimmune hepatitis in the United States. J Hepatol (1993) 1.29
RBC alloantibody specificity and antigen potency in Olmsted County, Minnesota. Transfusion (2001) 1.28
Linkage evidence for genetic heterogeneity among kinships with hereditary motor and sensory neuropathy, type I. Mayo Clin Proc (1983) 1.24
Delayed hemolytic transfusion reactions. Evidence of the need for an improved pretransfusion compatibility test. Am J Clin Pathol (1980) 1.24
Associations between alleles of the major histocompatibility complex and type 1 autoimmune hepatitis. Hepatology (1997) 1.16
The syndrome of gastric argyrophil carcinoid tumors and nonantral gastric atrophy. Ann Intern Med (1983) 1.15
Allelic basis for HLA-encoded susceptibility to type 1 autoimmune hepatitis. Gastroenterology (1997) 1.15
Bigger is better: maternal and neonatal predictors of hematopoietic potential of umbilical cord blood units. Bone Marrow Transplant (2001) 1.14
Histologic findings one year after positive crossmatch or ABO blood group incompatible living donor kidney transplantation. Am J Transplant (2006) 1.12
Increased bile duct complications in liver transplantation across the ABO barrier. Ann Surg (1993) 1.11
The dose of infused lymphocytes in the autograft directly correlates with clinical outcome after autologous peripheral blood hematopoietic stem cell transplantation in multiple myeloma. Leukemia (2004) 1.10
Influence of positive lymphocyte crossmatch and HLA mismatching on vanishing bile duct syndrome in human liver allografts. Transplantation (1988) 1.10
Trends in the incidence of delayed hemolytic and delayed serologic transfusion reactions. Transfusion (1999) 1.09
Delayed immune hemolysis in a patient receiving cyclosporine after orthotopic liver transplantation. Transfusion (1988) 1.07
Universal WBC reduction. Transfusion (2000) 1.06
Coronary artery disease in twins. Br Heart J (1981) 1.05
Mayo Clinic experience with allogeneic and syngeneic bone marrow transplantation, 1982 through 1990. Mayo Clin Proc (1992) 1.05
Infused peripheral blood autograft absolute lymphocyte count correlates with day 15 absolute lymphocyte count and clinical outcome after autologous peripheral hematopoietic stem cell transplantation in non-Hodgkin's lymphoma. Bone Marrow Transplant (2004) 1.05
Evidence that the liver does not always protect the kidney from hyperacute rejection in combined liver-kidney transplantation across a positive lymphocyte crossmatch. Transplantation (1990) 1.04
The nature and prognosis of severe cryptogenic chronic active hepatitis. Gastroenterology (1993) 1.04
Origin of chi46,XX/46,XY chimerism in a human true hermaphrodite. Science (1980) 1.03
Genetic predispositions for the immunological features of chronic active hepatitis. Hepatology (1993) 1.01
Perceptions and preferences of autologous blood donors. Transfusion (1998) 1.01
Computer interview for screening blood donors for risk of HIV transmission. MD Comput (1994) 1.00
Immunologic features and HLA associations in chronic viral hepatitis. Gastroenterology (1995) 0.99
Significance of HLA DR4 in type 1 autoimmune hepatitis. Gastroenterology (1993) 0.98
Palpation thyroiditis (multifocal granulomatour folliculitis). Am J Clin Pathol (1975) 0.97
Plasma exchange conditioning for ABO-incompatible renal transplantation. J Clin Apher (2004) 0.96
Serum IgG anti-native type II collagen antibodies in rheumatoid arthritis: association with HLA DR4 and lack of clinical correlation. Clin Exp Rheumatol (1989) 0.95
Hemochromatosis: genetic or alcohol-induced? Gastroenterology (1983) 0.94
Kidney transplantation in patients with antibodies against donor HLA class II. Am J Transplant (2007) 0.94
Associations of antibodies to native DNA with HLA-DRw3. A possible major histocompatibility complex-linked human immune response gene. J Exp Med (1980) 0.93
Red blood cell transfusion practices in patients undergoing orthopedic surgery: a multi-institutional analysis. Orthopedics (1998) 0.93
Thrombocytosis, coronary thrombosis and acute myocardial infarction. Am J Med (1979) 0.93
Immunologic, clinical, and pathologic aspects of human graft-versus-host disease. Mayo Clin Proc (1983) 0.91
Prevalence of TT virus infection in blood donors with elevated ALT in the absence of known hepatitis markers. Am J Gastroenterol (2000) 0.90
Mixed lymphocyte culture, phytohemagglutinin stimulation, and matching grade: clinical relevance in renal transplantation from living related donors. Transplantation (1980) 0.90
Severe ductopenic rejection following liver transplantation: incidence, time of onset, risk factors, treatment, and outcome. Semin Liver Dis (1992) 0.90
Infection with HIV-2 in a resident of the United States. N Engl J Med (1990) 0.90
Transfusion-transmitted babesiosis. Transfusion (1991) 0.90
Meyenburg complexes of the liver and bile cysts as a consequence of hepatic ischemia. Hum Pathol (1979) 0.90
Limited utility of alanine aminotransferase screening of hepatitis C antibody-screened blood donors. Transfusion (1997) 0.89
HLA and nasopharyngeal carcinoma in North American Caucasoids. Tissue Antigens (1983) 0.89
Intraoperative autologous transfusion. Mayo Clin Proc (1985) 0.88
Leukocyte reduction of blood components: public policy and new technology. Transfus Med Rev (2000) 0.88
Apheresis instrument settings influence infused absolute lymphocyte count affecting survival following autologous peripheral hematopoietic stem cell transplantation in non-Hodgkin's lymphoma: the need to optimize instrument setting and define a lymphocyte collection target. Bone Marrow Transplant (2006) 0.88
Autologous platelet-rich plasma isolated using the Haemonetics Cell Saver 5 and Haemonetics MCS+ for the preparation of platelet gel. Vox Sang (2001) 0.88
In search of marker for genetic susceptibility to reflux nephropathy. Clin Nephrol (1980) 0.88
Persistent centrilobular necroses in hepatic allografts. Hum Pathol (1990) 0.88
Lack of association between Behçet's disease and major histocompatibility complex class II antigens in an ethnically diverse North American Caucasoid patient group. J Rheumatol (1986) 0.88
Characterization of reactions after transfusion of cellular blood components that are white cell reduced before storage. Transfusion (1996) 0.88
Bile duct cysts secondary to liver infarcts: report of a case and experimental production by small vessel hepatic artery occlusion. Radiology (1979) 0.88
Delayed hemolysis resulting from anti-A1 after liver transplantation. Am J Clin Pathol (1989) 0.87
Acute occlusion of the posterior spinal vein. Experimental study in monkeys. J Neurosurg (1979) 0.87
HLA-DR locus antigens in polymyalgia rheumatica and giant cell arteritis. J Rheumatol (1982) 0.87
Predictive value of past and current screening tests for syphilis in blood donors: changing from a rapid plasma reagin test to an automated specific treponemal test for screening. Transfusion (1999) 0.87
Blood transfusion and septic complications after hip replacement surgery. Transfusion (1995) 0.86
Comparison of the polyethylene glycol antiglobulin test and the use of enzymes in antibody detection and identification. Transfusion (1996) 0.85
Anti-type II collagen antibodies in rheumatoid arthritis. The influence of HLA phenotype. Tissue Antigens (1984) 0.85
Primary biliary cirrhosis: associations with class II major histocompatibility complex antigens. Hepatology (1987) 0.85
The differentiation of delayed hemolytic and delayed serologic transfusion reactions: incidence and predictors of hemolysis. Transfusion (1995) 0.85
Blood transfusion and postoperative septic complications. Transfusion (1994) 0.85
HLA-DRB1 molecules and antigenic experience shape the repertoire of CD4 T cells. Hum Immunol (1995) 0.84
Association between major histocompatibility antigen and reproductive performance. Am J Reprod Immunol Microbiol (1987) 0.84
Genetic predispositions for immunological features in chronic liver diseases other than autoimmune hepatitis. J Hepatol (1996) 0.84
Anaphylactic transfusion reactions--a concise review. Ir Med J (1985) 0.84
Myelin oligodendrocyte glycoprotein antibodies in pathologically proven multiple sclerosis: frequency, stability and clinicopathologic correlations. Mult Scler (2007) 0.83
How important are ABO-related variations in coagulation factor levels? Transfusion (2001) 0.83
Roles of the neutrophil and other mediators in adult respiratory distress syndrome. Mayo Clin Proc (1989) 0.83
The safety of preoperative autologous blood donation in the nonhospital setting. Transfusion (1991) 0.82
Evidence for linkage of IgA deficiency with the major histocompatibility complex. Mayo Clin Proc (1988) 0.82